FLCN and metabolic dysfunction-associated steatotic liver disease: Furthermore, FLCN was shown to specifically activate the autophagy and lysosomal biogenesis while leaving mRNA translation machinery unperturbed, therefore, opening new possibilities for treatment strategies through its role in NAFLD and NASH by controlling hepatocyte homeostasis.